histazin syrup equivalent to promethazine 5 mg/5ml
الشركة المتحدة لصناعة الأدوية - united pharmaceutical manufacturing co. ltd. - promethazine hcl equivalent to promethazine 5 mg/5ml - equivalent to promethazine 5 mg/5ml
vanco (equivalent to vancomycin 500) mg
شركة أدوية الحكمة - hikma pharmaceuticals - vancomycin hcl (equivalent to vancomycin 500) mg - (equivalent to vancomycin 500) mg
zermacin 0.5g equivalent to 0.5 g vancomycin
مستودع ادوية أدونيس - adonis drug store - vancomycin hcl equivalent to 0.5 g vancomycin - equivalent to 0.5 g vancomycin
zermacin 0.5g equivalent to 0.5 g vancomycin
مستودع ادوية أدونيس - adonis drug store - vancomycin hcl equivalent to 0.5 g vancomycin - equivalent to 0.5 g vancomycin
vaxneuvance (pneumococcal 15-valent conjugate vaccine) suspension for injection prefilled syringe
merck sharp & dohme (malaysia) sdn bhd - monovalent conjugate bulk - pneumococcal polysaccharide serotype 1; monovalent conjugate bulk - pneumococcal polysaccharide serotype 3; monovalent conjugate bulk - pneumococcal polysaccharide serotype 4; monovalent conjugate bulk - pneumococcal polysaccharide serotype 5; monovalent conjugate bulk - pneumococcal polysaccharide serotype 6a; monovalent conjugate bulk - pneumococcal polysaccharide serotype 6b; monovalent conjugate bulk - pneumococcal polysaccharide serotype 7f; monovalent conjugate bulk - pneumococcal polysaccharide serotype 9v; monovalent conjugate bulk - pneumococcal polysaccharide serotype 14; monovalent conjugate bulk - pneumococcal polysaccharide serotype 18c; monovalent conjugate bulk - pneumococcal polysaccharide serotype 19a; monovalent conjugate bulk - pneumococcal polysaccharide serotype 19f; monovalent conjugate bulk - pneumococcal polysaccharide serotype 22f; monovalent conjugate bulk - pneumococcal polysaccharide serotype 23f; monovalent conjugate bulk - pneumococcal polysaccharide serotype 33f -
pneumococcal polysaccharide conjugate vaccine(adsorbed) (10 valent) 5 dose suspension for injection
serum institute of india pvt. ltd. (siipl), india - monovalent bulk conjugates (saccharides for each serotypes 1, 5, 6a, 6b, 9v, 7f, 14, 19a, 19f, 23f conjugated to crm197carrier protein) - suspension for injection - 2+4 mcg/0.5ml
pneumococcal polysaccharide conjugate vaccine(adsorbeb) (10 valent) 1 dose suspension for injection
serum institute of india pvt. ltd. (siipl), india - monovalent bulk conjugates (saccharides for each serotypes 1, 5, 6a, 6b, 9v, 7f, 14, 19a, 19f, 23f conjugated to crm197carrier protein) - suspension for injection - 2+4 mcg/0.5ml
polyvalent antivenom
tiger snake antivenom; taipan antivenom; death adder antivenom; black snake antivenom; brown snake antivenom -
flumist quadrivalent
astrazeneca (israel) ltd - a/darwin/9/2021 (h3n2)-like virus; a/victoria/4897/2022 (h1n1)pdm09-like virus; b/austria/1359417/2021 (b/victoria lineage)-like virus; b/phuket/3073/2013 (b/yamagata lineage)-like virus - nasal spray, suspension - b/phuket/3073/2013 (b/yamagata lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/darwin/9/2021 (h3n2)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; b/austria/1359417/2021 (b/victoria lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/victoria/4897/2022 (h1n1)pdm09-like virus 7 ±0.5 log10 ffu^a / 0.2 ml - influenza, inactivated, split virus or surface antigen - influenza, purified antigen - flumist quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza a subtype viruses ad type b viruses contained in the vaccine. flumist quadrivalent is approved for use in persons 2 through 49 years of age.
fluzone high-dose qiv inactivated quadrivalent influenza vaccine (split virion) influenza virus haemagglutinin 240 mcg, suspension for injection pfs, sh2024 season
sanofi-aventis australia pty ltd - influenza virus haemagglutinin, quantity: 60 microgram - injection, suspension - excipient ingredients: octoxinol 9; monobasic sodium phosphate; water for injections; dibasic sodium phosphate; sodium chloride - fluzone high-dose quadrivalent (qiv) is indicated for active immunisation for the prevention of influenza disease. fluzone high-dose quadrivalent is indicated for use in persons 60 years of age and older., the use of fluzone high-dose quadrivalent (qiv) should be based on official recommendations., see section 5.1 clinical trials for information on the effects on influenza associated complications.